PURPOSE: To evaluate pregabalin (PGB), 150 mg/day, and PGB, 600 mg/day, as an add-on treatment for patients with refractory partial seizures concurrently treated with one to three anticonvulsants (AEDs). METHODS: An international (13 countries), multicenter (45 centers), 12-week, double-blind, rando...
No comments yet
Be the first to share your thoughts!